BioCryst Pharmaceuticals, Inc.
USD8.34
-0.23 (-2.68%)
CEO
Charles K. Gayer
IPO Date
1994-03-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.42
Prev. Close
$8.57
Day Low
$8.25
Day High
$8.45
52W Low
$6.00
52W High
$11.31
Market Cap
$1.75B
Volume
3.63M
| 62,500 |
| $5.04 |
| 15 May 2026 | Barnes Alane P | Chief Legal Officer | S-Sale | Disposed | 62,500 | $9.54 |
| 15 May 2026 | Barnes Alane P | Chief Legal Officer | M-Exempt | Disposed | 62,500 | $5.04 |
| 7 Apr 2026 | Menon Sandeep | Chief R&D Officer | A-Award | Acquired | 205,150 | $0.00 |
| 7 Apr 2026 | Menon Sandeep | Chief R&D Officer | A-Award | Acquired | 441,350 | $9.47 |
| 7 Apr 2026 | Menon Sandeep | officer | Disposed | 0 | $0.00 |
| 24 Mar 2026 | HEGGIE THERESA | director | M-Exempt | Acquired | 49,933 | $6.30 |
| 24 Mar 2026 | HEGGIE THERESA | director | S-Sale | Disposed | 49,933 | $10.11 |
| 24 Mar 2026 | HEGGIE THERESA | director | M-Exempt | Disposed | 49,933 | $6.30 |
| $1,001 - $15,000 |
| 16 Sept 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |